• Lepu Scientech will hold an extraordinary general meeting in Shanghai on December 2, 2026.
• Shareholders will vote on acquiring a 54.24% stake in Shanghai Minwei Biotechnology for RMB 1.09 billion in cash.
• A separate proposal would reallocate HKD 160.8 million of unused offering proceeds to strategic investments and acquisitions, bringing the allocation to HKD 185.7 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lepu Scientech Medical Technology Shanghai Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261112-12410572), on November 12, 2026, and is solely responsible for the information contained therein.